KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Inventory (2016 - 2025)

Historic Inventory for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $13.7 billion.

  • Eli Lilly's Inventory rose 8110.42% to $13.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $13.7 billion, marking a year-over-year increase of 8110.42%. This contributed to the annual value of $13.7 billion for FY2025, which is 8110.42% up from last year.
  • According to the latest figures from Q4 2025, Eli Lilly's Inventory is $13.7 billion, which was up 8110.42% from $12.2 billion recorded in Q3 2025.
  • Eli Lilly's Inventory's 5-year high stood at $13.7 billion during Q4 2025, with a 5-year trough of $3.7 billion in Q1 2021.
  • In the last 5 years, Eli Lilly's Inventory had a median value of $4.9 billion in 2023 and averaged $6.3 billion.
  • Its Inventory has fluctuated over the past 5 years, first crashed by 236.92% in 2021, then soared by 8110.42% in 2025.
  • Quarter analysis of 5 years shows Eli Lilly's Inventory stood at $3.9 billion in 2021, then increased by 10.9% to $4.3 billion in 2022, then surged by 33.95% to $5.8 billion in 2023, then surged by 31.46% to $7.6 billion in 2024, then surged by 81.1% to $13.7 billion in 2025.
  • Its last three reported values are $13.7 billion in Q4 2025, $12.2 billion for Q3 2025, and $11.0 billion during Q2 2025.